跳至主要内容
临床试验/IRCT20230128057262N1
IRCT20230128057262N1招募中2 期

To evaluate the feasibility and safety of hypofractionated radiotherapy in early laryngeal cancers: a phase 2 clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 49 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
49

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Definitive diagnosis of squamous cell carcinoma of the larynx based on pathology report
  • Glottic lesions T1-2
  • No involvement of neck lymph nodes (N0)
  • 18 to 75 years old
  • Performance level based on ECOG less than 3

排除标准

  • Other malignant histologies of the larynx except squamous cell carcinoma
  • History of head and neck radiotherapy
  • Previous history of chemotherapy
  • Previous history of malignancy except skin BCC
  • History of diabetes or uncontrolled blood pressure
  • History of tracheostomy
  • With a history of laser microsurgery

研究者

相似试验